Tert-butyl 2-methylaziridine-1-carboxylate → (S)-N-tert-butoxycarbonyl 1-(5-fluorobenzofur-7-yl)-2-aminopropane
Reaktionsgleichung
[F:1][C:2]1[CH:3]=[C:4](Br)[C:5]2[O:9][CH:8]=[CH:7][C:6]=2[CH:10]=1.[C:12]([O:16][C:17]([N@:19]1[CH2:21][CH:20]1[CH3:22])=[O:18])([CH3:15])([CH3:14])[CH3:13]>>[C:12]([O:16][C:17]([NH:19][C@@H:20]([CH3:22])[CH2:21][C:4]1[C:5]2[O:9][CH:8]=[CH:7][C:6]=2[CH:10]=[C:2]([F:1])[CH:3]=1)=[O:18])([CH3:15])([CH3:14])[CH3:13]Komponenten
3
Versuchsvorschrift
Beginning with 0.94 gm (4.4 mMol) 5-fluoro-7-bromobenzofuran and 0.63 mg (4 mMol) (S)-(+)-N-tert-butoxycarbonyl-2-methylaziridine, 0.534 gm (46%) of the desired compound were prepared essentially as described in Example 10.
Quellen und Nachweise
- ORD-Eintrag
- ord-dfc591ea0ee4497aaa8d5f34f40ff73d
- Quelldatensatz
- uspto-grants-2006_05